December 28, 2014 12:34 AM ET


Company Overview of Milestone Pharmaceuticals Inc.

Executive Profile

Juan Guerrero M.D.

Member of the Scientific Advisory Board, Milestone Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships


Juan Guerrero, M.D. serves as Chief Medical Officer and Director of ECG CorLab at Vinsys H.C. Dr. Guerrero played key roles in planning and implementing first proof of concept studies for important cardiovascular therapeutic classes, and other novel protocol designs in cardiovascular medicine. Dr. Guerrero planned and implemented the first studies to prove the then pioneering (and in 1973, as yet not accepted) concept of angiotensin converting enzyme inhibition with ...

Corporate Headquarters

6100 Royalmount Avenue
Montreal, Quebec H4P 2R2


Phone: 514-496-3220
Fax: 514-496-3219

Board Members Memberships

There is no Board Members Memberships data available.


There is no Education data available.

Other Affiliations

There is no Company Affiliations data available.

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Milestone Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at